Eupraxia Pharmaceuticals Inc. ('Eupraxia' or the 'Company') (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize ...
Meudon, on July 7th, 2026 - Vallourec, a world leader in premium seamless tubular solutions, announces that its science-based decarbonization pathway has been certified by the Global Steel Climate ...
Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging ...
Malawi is expanding universities and technical colleges through the World Bank-backed SAVE project to improve access to higher education The $100 million program aims to equip students with skills ...
Dhruv Khullar on the latest research on GLP-1 drugs, which, though typically used to manage diabetes and obesity, are showing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results